APF, HB-EGF, and EGF biomarkers in patients with ulcerative vs. non-ulcerative interstitial cystitis

BMC Urology

Volumn 5, Issue , 2005, Pages

  Zhang, Chen Ou ^a   Li, Ze Liang ^b   Kong, Chui Ze ^c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b CHINA MEDICAL UNIVERSITY   (China)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR;

ADULT; ARTICLE; BLADDER CANCER; BLOOD LEVEL; CHINESE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INTERSTITIAL CYSTITIS; MAJOR CLINICAL STUDY; MEASUREMENT; URINALYSIS;

ADULT; BIOLOGICAL MARKERS; CHINA; CYSTITIS, INTERSTITIAL; EPIDERMAL GROWTH FACTOR; FEMALE; GLYCOPROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; ULCER; URINARY BLADDER DISEASES;

EID: 21444456330     PISSN: 14712490     EISSN: 14712490     Source Type: Journal    
DOI: 10.1186/1471-2490-5-7     Document Type: Article

References (18)

1. Hanno PM, Staskin DR, Krane RJ, Wein AJ, eds: Interstitial cystitis. Springer-Verlag, London; 1990.
2. Division of Kidney, Urologic, and Hematologic Diseases (DKUHD) of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): Diagnostic criteria for research studies (interstitial cystitis). Am J Kidney Dis 1989, 13:353-354.
3. Zhang C-O, Li Z-L, Shoenfelt JL, Kong C-Z, Chai TC, Erickson DE, Peters KM, Rovner ES, Keay S: Comparison of APF activity and epithelial growth factor levels in urine from Chinese, African American and Caucasian American IC patients. Urology 2003, 61:897-901.
4. Keay S, Zhang C-O, Shoenfelt JL, Erickson DR, Whitmore K, Warren JW, Marvel R, Chai T: Sensitivity and specificity of antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor as urine markers for interstitial cystitis. Urology 2001, 57(Suppl 6A):9-14.
5. Erickson DR, Xie SX, Bhavanandan VP, Wheeler MA, Hurst RE, Demers LM, Kushner L, Keay SK: A comparison of multiple urine markers for interstitial cystitis. J Urol 2002, 167:2461-2469.
6. Keay S, Szekely Z, Conrads TP, Veenstra TD, Barchi JJ Jr, Zhang C-O, Koch KR, Michejda CJ: An antiproliferative factor from interstitial cystitis patients is a frizzled 8 protein-related sialoglycopeptide. PNAS 2004, 101:11803-11808.
7. O'Leary MP, Sant GR, Fowler FJ, Whitmore KE, Spolarich-Kroll J: The interstitial cystitis symptom index and problem index. Urology 1997, 49(suppl 5A):58-63.
8. Keay S, Kleinberg M, Zhang C-O, Hise MK, Warren JW: Bladder epithelial cells from interstitial cystitis patients produce an inhibitor of HB-EGF production. J Urol 2000, 64:2112-2118.
9. Tomaszewski JE, Landis JR, Russack V, Williams TM, Wang LP, Hardy C, Brensinger C, Matthews YL, Abele ST, Kusek JW, Nyberg LM: Biopsy features are associated with primary symptoms in interstitial cystitis: results from the interstitial cystitis database study. Urology 2001, 57(Suppl 6A):67-81.
10. Freeman MR, Yoo JJ, Raab G, Soker S, Adam RM, Schneck FX, Renshaw AA, Klagsbrun M, Atala A: Heparin-binding EGF-like growth factor is an autocrine growth factor for human urothelial cells and is synthesized by epithelial and smooth muscle cells in the human bladder. J Clin Invest 1997, 99:1028-1036.
11. Keay S, Zhang C-O, Kagen DI, Hise MK, Jacobs SC, Hebel JR, Gordon D, Whitmore K, Bodison S, Warren JW: Concentrations of specific epithelial growth factor in the urine of interstitial cystitis patients and controls. J Urol 1997, 158:1983-1988.
12. Keay S, Takeda M, Tamaki M, Hanno P: Current and future directions in diagnostic markers in interstitial cystitis. International J Urol 2003, 10:S27-S30.
13. Byrne DS, Sedor JF, Estojak J, Fitzpatrick KJ, Chiura AN, Mulholland SG: The urinary glycoprotein GP51 as a clinical marker for interstitial cystitis. J Urol 1999, 161:1786-1790.
14. Smith SD, Wheeler MA, Foster HE Jr, Weiss RM: Urinary nitric oxide synthase activity and cyclic GMP levels are decreased with interstitial cystitis and increased with urinary tract infections. J Urol 1996, 155:1432-1435.
15. Ehren I, Hosseini A, Lundberg JO, Wiklund NP: Nitric oxide: A useful gas in the detection of lower urinary tract inflammation. J Urol 1999, 162:327-329.
16. Ehren I, Hosseini A, Herulf M, Lundberg JO, Wiklund NP: Measurement of luminal nitric oxide in bladder inflammation using a silicon balloon catheter: A novel minimally invasive method. Urology 1999, 54:264-267.
17. Ueda T, Tamaki M, Ogawa O, Yamauchi T, Yoshimura N: Improvement of interstitial cystitis and problems that developed during treatment with oral IPD-1151T. J Urol 2000, 164:1917-1920.
18. Chang SG, Lee SJ, Huh JS, Lee JH: Changes in mucosal immune cells of bladder tumor patient after BCG intravesical immunotherapy. Oncol Rep 2001, 8:257-261.